Linda C. Laux, MD

Medical Director, Comprehensive Epilepsy Center

Associate Professor of Pediatrics (Neurology and Epilepsy), Northwestern University Feinberg School of Medicine

Language: English

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Pediatric epilepsy, Dravet syndrome (severe myoclonic epilepsy of infancy)

Specialties, Programs & Conditions

Specialties:

Neurology

Programs & Conditions:

Education & Training

Education: St. Louis University, 1990

Postgraduate Training: Fellowship in pediatric epilepsy, Children's Memorial Hospital, 2001; Fellowship in neurology/child neurology, Barrow's Neurologic Institute/St. Joseph's Hospital, Phoenix, AZ, 1994-1997; Residency in pediatrics, University of Arizona Health Science Center, 1990-1993

Board Certifications: Neurology with special qualifications in Child Neurology

Professional Organizations: American Clinical Neurophysiology Society; American Epilepsy Society; Child Neurology Society

See Northwestern University Faculty Profile >

Research

Northwestern Scholars Profile >

Publications

Most recent publications

Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial Epilepsia
Open-label use of highly purified CBD (Epidiolex(R)) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes Epilepsy Behav86131-137
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results Epilepsia
Severe peri-ictal respiratory dysfunction is common in Dravet syndrome J Clin Invest128 (3): 1141-1153
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome N Engl J Med376 (21): 2011-2020
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy Ann Clin Transl Neurol4 (5): 326-339
Seizure Outcomes in Children Following Electrocorticography-Guided Single-Stage Surgical Resection Pediatr Neurol7135-42
Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases J Child Neurol32 (1): 35-40
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurol15 (3): 270-8
Ictal ontogeny in Dravet syndrome Clin Neurophysiol126 (3): 446-55

See All

Call for Insurance information: 1.800.543.7362

News

2 Results

Precision Medicine a Game-Changer in Treating Early Life Epilepsy

Cannabidiol Reduces Seizures in Children with Severe Epilepsy

See all News & Stories >

Linda C. Laux, MD

Linda C. Laux, MD

Medical Director, Comprehensive Epilepsy Center

Associate Professor of Pediatrics (Neurology and Epilepsy), Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Specialties, Programs & Conditions

Education & Training

Research

Publications

Call for Insurance information: 1.800.543.7362

Location

News

Precision Medicine a Game-Changer in Treating Early Life Epilepsy

Cannabidiol Reduces Seizures in Children with Severe Epilepsy